SEC Form 4 · accession 0001615774-16-005043
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Greenberg
Officer — Chairman of Board · Director
Period of report
Apr 18, 2016
Accepted (ET)
Apr 20, 2016 · 3:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 18, 2016 | M | 8,223 | $5.00 | A | 181,134 | D | |
| Common Stock | Apr 18, 2016 | S | 8,223 | $5.2688 | D | 172,911 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $5.00 | Apr 18, 2016 | M | — | D | May 1, 2007 | May 1, 2016 | Common Stock | 8,223 | 0 | D |
| Non-Qualified Stock Option (right to buy)F1 | $4.10 | holding | — | — | — | Jan 21, 2017 | Jan 21, 2026 | Common Stock | 57,563 | 57,563 | D |
| Non-Qualified Stock Option (right to buy)F2 | $5.00 | holding | — | — | — | Jan 1, 2008 | Jan 1, 2017 | Common Stock | 30,625 | 30,625 | D |
| Non-Qualified Stock Option (right to buy)F2 | $5.00 | holding | — | — | — | Feb 1, 2009 | Feb 1, 2018 | Common Stock | 23,750 | 23,750 | D |
| Non-Qualified Stock Option (right to buy)F2 | $5.00 | holding | — | — | — | Nov 1, 2009 | Nov 1, 2018 | Common Stock | 150,000 | 150,000 | D |
| Non-Qualified Stock Option (right to buy)F2 | $5.00 | holding | — | — | — | Feb 1, 2010 | Feb 1, 2019 | Common Stock | 33,750 | 33,750 | D |
| Non-Qualified Stock Option (right to buy)F2 | $5.00 | holding | — | — | — | Feb 1, 2011 | Feb 1, 2020 | Common Stock | 103,750 | 103,750 | D |
| Non-Qualified Stock Option (right to buy)F2 | $5.00 | holding | — | — | — | Mar 1, 2012 | Mar 1, 2021 | Common Stock | 41,563 | 41,563 | D |
| Non-Qualified Stock Option (right to buy)F2 | $5.00 | holding | — | — | — | Mar 1, 2013 | Mar 1, 2022 | Common Stock | 38,750 | 38,750 | D |
| Non-Qualified Stock Option (right to buy)F3 | $4.25 | holding | — | — | — | Jan 1, 2014 | Jan 1, 2017 | Common Stock | 125,000 | 125,000 | D |
| Non-Qualified Stock Option (right to buy)F2 | $5.00 | holding | — | — | — | Apr 1, 2015 | Apr 1, 2024 | Common Stock | 46,875 | 46,875 | D |
| Non-Qualified Stock Option (right to buy)F2 | $9.00 | holding | — | — | — | Sep 26, 2015 | Sep 26, 2024 | Common Stock | 414,659 | 414,659 | D |
| Non-Qualified Stock Option (right to buy)F2 | $13.09 | holding | — | — | — | Mar 25, 2016 | Mar 25, 2025 | Common Stock | 31,250 | 31,250 | D |
Explanation of responses
- F1Options vest over a four year term of which one-fourth vest on the exercise date, with the remaining options vesting quarterly over three years thereafter.
- F2Options vest in 4 yearly increments starting with the Date Exercisable
- F3Option vested at date of grant.
Remarks
Price reported in Column 4, Table I is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.29 inclusive. The reporting person undertakes to provide the issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price. These transactions were automatically effected pursuant to Rule 10b5-1 trading plan.